These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2681272)

  • 1. Insulin transport across capillaries is rate limiting for insulin action in dogs.
    Yang YJ; Hope ID; Ader M; Bergman RN
    J Clin Invest; 1989 Nov; 84(5):1620-8. PubMed ID: 2681272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response relationship between lymph insulin and glucose uptake reveals enhanced insulin sensitivity of peripheral tissues.
    Yang YJ; Hope I; Ader M; Poulin RA; Bergman RN
    Diabetes; 1992 Feb; 41(2):241-53. PubMed ID: 1733816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph.
    Poulin RA; Steil GM; Moore DM; Ader M; Bergman RN
    Diabetes; 1994 Feb; 43(2):180-90. PubMed ID: 8288041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the transcapillary insulin transport in the efficiency of insulin action: studies with glucose clamps and the minimal model.
    Bergman RN; Yang YJ; Hope ID; Ader M
    Horm Metab Res Suppl; 1990; 24():49-56. PubMed ID: 2272626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of transcapillary transport of insulin and insulin analog NN304 in dog hindlimb: evidence for passive diffusion.
    Hamilton-Wessler M; Ader M; Dea MK; Moore D; Loftager M; Markussen J; Bergman RN
    Diabetes; 2002 Mar; 51(3):574-82. PubMed ID: 11872653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for direct action of alloxan to induce insulin resistance at the cellular level.
    Ader M; Richey JM; Bergman RN
    Diabetologia; 1998 Nov; 41(11):1327-36. PubMed ID: 9833941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects.
    Prager R; Wallace P; Olefsky JM
    J Clin Invest; 1986 Aug; 78(2):472-81. PubMed ID: 3525609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of transcapillary insulin transport to dynamics of insulin action after intravenous glucose.
    Yang YJ; Hope ID; Ader M; Bergman RN
    Am J Physiol; 1994 Jan; 266(1 Pt 1):E17-25. PubMed ID: 8304440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphasic insulin secretion during intravenous glucose tolerance test promotes optimal interstitial insulin profile.
    Getty L; Hamilton-Wessler M; Ader M; Dea MK; Bergman RN
    Diabetes; 1998 Dec; 47(12):1941-7. PubMed ID: 9836528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed transcapillary transport of insulin to muscle interstitial fluid in obese subjects.
    Sjöstrand M; Gudbjörnsdottir S; Holmäng A; Lönn L; Strindberg L; Lönnroth P
    Diabetes; 2002 Sep; 51(9):2742-8. PubMed ID: 12196467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components.
    Ader M; Ni TC; Bergman RN
    J Clin Invest; 1997 Mar; 99(6):1187-99. PubMed ID: 9077526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
    Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel hepatoselective insulin analogues: studies with covalently linked thyroxyl-insulin complexes.
    Shojaee-Moradie F; Eckey H; Jackson NC; Schüttler A; Brandenburg D; Sönksen PH; Jones RH
    Diabet Med; 1998 Nov; 15(11):928-36. PubMed ID: 9827847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of insulin action in vivo. Identification of rate-limiting steps.
    Miles PD; Levisetti M; Reichart D; Khoursheed M; Moossa AR; Olefsky JM
    Diabetes; 1995 Aug; 44(8):947-53. PubMed ID: 7622001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentobarbital reduces basal liver glucose output and its insulin suppression in rats.
    Clark PW; Jenkins AB; Kraegen EW
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E701-7. PubMed ID: 2185651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transendothelial insulin transport is not saturable in vivo. No evidence for a receptor-mediated process.
    Steil GM; Ader M; Moore DM; Rebrin K; Bergman RN
    J Clin Invest; 1996 Mar; 97(6):1497-503. PubMed ID: 8617883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin insensitivity and delayed transcapillary delivery of insulin in oophorectomized rats treated with testosterone.
    Holmäng A; Niklasson M; Rippe B; Lönnroth P
    Acta Physiol Scand; 2001 Apr; 171(4):427-38. PubMed ID: 11421858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indomethacin and salicylate modulate effect of insulin on glucose kinetics in dogs.
    Miller JD; Ganguli S; Sperling MA
    Am J Physiol; 1985 Jun; 248(6 Pt 1):E648-55. PubMed ID: 3923840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of parathyroid hormone in the glucose intolerance of chronic renal failure.
    Akmal M; Massry SG; Goldstein DA; Fanti P; Weisz A; DeFronzo RA
    J Clin Invest; 1985 Mar; 75(3):1037-44. PubMed ID: 3884663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.